Rockwell Medical Q3 net sales fall 44% to $15.9M; net loss of $1.8M vs profit year ago

ROCKWELL MEDICAL, INC.

2025-Q3 EPS reported -$0.14 revenue$50,912,000

Net sales $15.9M, down 44% YoY due to largest customer transitioning to another supplier.
Net loss of $1.8M compared to net income of $1.7M in Q3 2024; Adjusted EBITDA virtually breakeven at $50k.
Gross margin contracted to 14% (18% excluding restructuring) from 22% a year ago.
Cash increased to $23.7M from $18.4M at June 30, driven by ATM stock issuance.
Reaffirms 2025 guidance: net sales $65-70M, gross margin 16-18%, Adjusted EBITDA ($0.5M)-$0.5M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.